Literature DB >> 11216198

Stroke thrombolysis: is tissue plasminogen activator a defibrillator for the brain?

A M Buchan1, T E Feasby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11216198      PMCID： PMC1232229     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  t-PA: a cause for tentative celebration.

Authors:  A M Hakim
Journal:  Can J Neurol Sci       Date:  1998-08       Impact factor: 2.104

Review 2.  Thrombolytic therapy in acute stroke: neurologists, get off your hands!

Authors:  S H Horowitz
Journal:  Arch Neurol       Date:  1998-02

3.  Acute stroke: usefulness of early CT findings before thrombolytic therapy.

Authors:  R von Kummer; K L Allen; R Holle; L Bozzao; S Bastianello; C Manelfe; E Bluhmki; P Ringleb; D H Meier; W Hacke
Journal:  Radiology       Date:  1997-11       Impact factor: 11.105

4.  Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window.

Authors:  J C Baron; R von Kummer; G J del Zoppo
Journal:  Stroke       Date:  1995-12       Impact factor: 7.914

5.  Canadian guidelines for intravenous thrombolytic treatment in acute stroke. A consensus statement of the Canadian Stroke Consortium.

Authors:  J W Norris; A Buchan; R Cote; V Hachinski; S J Phillips; A Shuaib; F Silver; D Simard; P Teal
Journal:  Can J Neurol Sci       Date:  1998-08       Impact factor: 2.104

6.  Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke.

Authors:  A M Demchuk; L B Morgenstern; D W Krieger; T Linda Chi; W Hu; T H Wein; R J Hardy; J C Grotta; A M Buchan
Journal:  Stroke       Date:  1999-01       Impact factor: 7.914

7.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

Authors:  W Hacke; M Kaste; C Fieschi; R von Kummer; A Davalos; D Meier; V Larrue; E Bluhmki; S Davis; G Donnan; D Schneider; E Diez-Tejedor; P Trouillas
Journal:  Lancet       Date:  1998-10-17       Impact factor: 79.321

8.  Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators.

Authors:  H J Barnett; D W Taylor; M Eliasziw; A J Fox; G G Ferguson; R B Haynes; R N Rankin; G P Clagett; V C Hachinski; D L Sackett; K E Thorpe; H E Meldrum; J D Spence
Journal:  N Engl J Med       Date:  1998-11-12       Impact factor: 91.245
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.